Target- |
MechanismCell wall inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date31 Dec 1944 |
100 Clinical Results associated with Kasten, Inc.
0 Patents (Medical) associated with Kasten, Inc.
100 Deals associated with Kasten, Inc.
100 Translational Medicine associated with Kasten, Inc.